% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{FuentesCasan:153342,
author = {Fuentes Casan, Manuel and Klostermann, Arne and Kleineidam,
Luca and Bauer, Chris and Schuchhardt, Johannes and Maier,
Wolfgang and Jessen, Frank and Frölich, Lutz and Wiltfang,
Jens and Kornhuber, Johannes and Klöppel, Stefan and
Schieting, Vera and Teipel, Stefan J. and Wagner, Michael
and Peters, Oliver},
title = {{I}dentification of a {C}ascade of {C}hanges in
{A}ctivities of {D}aily {L}iving {P}receding {S}hort-{T}erm
{C}linical {D}eterioration in {M}ild {A}lzheimer’s
{D}isease {D}ementia via {L}ead-{L}ag {A}nalysis},
journal = {Journal of Alzheimer's disease},
volume = {76},
number = {3},
issn = {1875-8908},
address = {Amsterdam},
publisher = {IOS Press},
reportid = {DZNE-2020-01339},
pages = {1005 - 1015},
year = {2020},
abstract = {Background:Cognitive functions and activities of daily
living (ADL) become increasingly impaired with progressing
Alzheimer’s disease. However, the temporal dynamics of
this decline are inconsistent.Objective:To gain insight into
the classical temporal cascade of specific cognitive and ADL
changes, which may aid in improving detection of an
impending clinical deterioration in patients, and to select
ADL items and tests most sensitive to change in a specific
disease stage.Methods:Patients with mild Alzheimer’s
dementia (AD; MMSE = 23.9±2.88) were followed at 12 and
24 months. Lead-lag analysis of changes in cognitive and
functional outcome measures (CDR-SOB, 12 neuropsychological
subtest scores from the CERAD + test battery, 25
Bayer-ADL items) was applied to rank the temporal sequence
of changes on an ordinal scale.Results:Of 164 patients with
mild AD, moderate disease progression was identified in 84
patients over 24 months (ΔMMSE 5.8±8.64; ΔCDR-SOB
4.32±4.03). Ten Bayer-ADL item measures were altered early
in moderate progressors and included in a new ADL composite
score. Accordingly, the new ADL score surpassed all
neuropsychological measures in repeated lead-lag analysis.
The Bayer-ADL total score, TMT-A, and MMSE were lagging
variables in all lead-lag analyses.Conclusion:Short-term
clinical deterioration in mild AD is initially preceded by
changes (i.e., decline) in a well-defined set of ADL and not
in classical cognitive measures.},
keywords = {Activities of Daily Living: psychology / Aged / Alzheimer
Disease: psychology / Clinical Deterioration / Cognition:
physiology / Disease Progression / Female / Humans / Male /
Neuropsychological Tests / Time Factors},
cin = {AG Endres / AG Wiltfang / U Clinical Researchers - Bonn /
AG Teipel / AG Wagner},
ddc = {610},
cid = {I:(DE-2719)1811005 / I:(DE-2719)1410006 /
I:(DE-2719)7000001 / I:(DE-2719)1510100 /
I:(DE-2719)1011201},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342) / 344
- Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-342 / G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32597807},
pmc = {pmc:PMC7504993},
doi = {10.3233/JAD-200230},
url = {https://pub.dzne.de/record/153342},
}